K2X Technology & Life Science, Inc.
KBPH
OTC PK
| 12/31/2021 | 09/30/2021 | 06/30/2021 | 03/31/2021 | 12/31/2020 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -96.48% | -115.00% |
| Total Other Revenue | 86.84% | -109.62% | -104.59% | -104.59% | -125.85% |
| Total Revenue | 84.85% | -108.77% | -104.39% | -100.00% | -115.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 86.84% | -109.62% | -104.59% | -103.52% | -117.27% |
| SG&A Expenses | 121.40% | 378.30% | 870.78% | -25.28% | -44.51% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 29.17% | 58.15% | 44.93% | 12.52% | 426.59% |
| Total Operating Expenses | 46.80% | 96.59% | 95.51% | 0.51% | 100.68% |
| Operating Income | -46.23% | -98.29% | -99.62% | -2.62% | -112.16% |
| Income Before Tax | 1,420.49% | 570.44% | 121.63% | 155.21% | 82.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 1,420.49% | 570.44% | 121.63% | 155.21% | 82.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 1,420.49% | 570.44% | 121.63% | 155.21% | 82.34% |
| EBIT | -46.23% | -98.29% | -99.62% | -2.62% | -112.16% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 686.99% | 339.86% | 148.14% | 152.00% | 81.40% |
| Normalized Basic EPS | 12.91% | -15.35% | -36.95% | 12.57% | -98.12% |
| EPS Diluted | 155.80% | 126.37% | 97.04% | 111.62% | 37.45% |
| Normalized Diluted EPS | 32.04% | 29.21% | 34.41% | 67.67% | -39.20% |
| Average Basic Shares Outstanding | 79.93% | 80.29% | 48.44% | 16.61% | -3.23% |
| Average Diluted Shares Outstanding | 104.53% | 169.99% | 270.44% | 238.61% | 81.86% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
